<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368236/" ref="ordinalpos=461&amp;ncbi_uid=4051032&amp;link_uid=PMC3368236" image-link="/pmc/articles/PMC3368236/figure/F5/" class="imagepopup">Figure 5.  From: Semaphorin <span class="highlight" style="background-color:">Signaling</span> in Vertebrate Neural Circuit Assembly. </a></div><br /><div class="p4l_captionBody"><b>Sema3E-PlexD1 signaling regulates pathway-specific synapse formation in the striatum</b>. Direct and indirect pathway MSNs are functionally and molecularly distinct. Direct pathway MSNs express type 1 dopamine receptors (Drd1) and indirect pathway MSNs express type 2 dopamine receptors (Drd2). PlexD1 is exprsssed by Drd1on-direct pathway MSNs in the striatum, whereas Sema3E is expressed by subsets of neurons in the main thalamic nuclei that project to the striatum. Loss of Sema3E-PlexD1 signaling causes functional and anatomical rearrangement of thalamostriatal synapses specifically in direct pathway MSNs without effects on corticostriatal synapses.</div></div>